Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Agilon Health (AGL) Depreciation & Amortization (IS) (2020 - 2025)

Agilon Health's Depreciation & Amortization (IS) history spans 6 years, with the latest figure at $7.0 million for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (IS) rose 7.31% year-over-year to $7.0 million; the TTM value through Dec 2025 reached $28.6 million, up 16.89%, while the annual FY2025 figure was $28.6 million, 16.89% up from the prior year.
  • Depreciation & Amortization (IS) reached $7.0 million in Q4 2025 per AGL's latest filing, down from $7.4 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (IS) ranged from a high of $8.9 million in Q4 2023 to a low of -$439000.0 in Q4 2021.
  • Average Depreciation & Amortization (IS) over 5 years is $4.9 million, with a median of $4.2 million recorded in 2023.
  • Peak YoY movement for Depreciation & Amortization (IS): plummeted 111.96% in 2021, then soared 989.98% in 2022.
  • A 5-year view of Depreciation & Amortization (IS) shows it stood at -$439000.0 in 2021, then skyrocketed by 989.98% to $3.9 million in 2022, then surged by 126.59% to $8.9 million in 2023, then dropped by 26.65% to $6.5 million in 2024, then rose by 7.31% to $7.0 million in 2025.
  • Per Business Quant, the three most recent readings for AGL's Depreciation & Amortization (IS) are $7.0 million (Q4 2025), $7.4 million (Q3 2025), and $7.3 million (Q2 2025).